Perrigo replaces CEO Rohrhoff with consumer goods veteran
Reuters
Published Oct 08, 2018 06:24PM ET
Perrigo replaces CEO Rohrhoff with consumer goods veteran
(Reuters) - Perrigo Co Plc (N:PRGO) on Monday replaced its chief executive officer of 10 months, Uwe Rohrhoff, with consumer goods industry veteran Murray Kessler, as the generic drugmaker sharpens its focus on consumer healthcare business.
Kessler has spent nearly three decades in consumer packaged goods business and has worked with Campbell Soup Co (N:CPB) and Clorox (N:CLX). He was most recently the chief executive officer and president at the Lorillard Tobacco Co [LO.UL].
Lorillard's market value surged to about $28 billion from about $9 billion during Kessler's tenure as CEO between 2010 and 2015, Perrigo said. Lorillard was acquired by Reynolds American Inc (N:RAI) in 2015.
Earlier this year, Perrigo said it would separate its generics prescription business, which has been a drag on results, to focus on consumer healthcare following a strategic review.
"Given the decision to separate the Rx pharmaceuticals business and pursue a consumer-focused strategy, the board is looking forward to partnering with him to develop Perrigo's strategic plan," board Chairman Rolf Classon said in a statement.
The separation of the generics prescription business is expected to be completed in the second half of 2019, with the board exploring all options, including a possible tax-efficient separation to shareholders, a sale or merger, the company has said.
Rohrhoff, who joined Perrigo in January, spent seven years as chief executive of Gerresheimer AG (DE:GXIG).
Under Rohrhoff, Perrigo's shares have shed 21 percent of their value, through Monday's close.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.